Fact CheckerSign in

NCT07141212Not yet recruiting

Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients

Source: ClinicalTrials.gov · Last updated 26 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Purpose of the Study This study will be conducted to determine the effect of virtual reality on pulmonary function and anxiety levels in moderate to severe asthmatic patients.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
22 Jul 2025
Start date
30 Aug 2025
Primary completion date
Dec 2025
Lead sponsor
October 6 University
Diseases
Asthma
NCT number
NCT07141212

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 30 Aug 2025 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous participation in any pulmonary rehabilitation program.

Other illness

  • Cardiovascular instabilities such as: Uncontrolled hypertension, Uncontrolled arrhythmia and Recent ischemic event.
  • Mental disorders preventing protocol implementation.
  • Other chronic respiratory diseases.
  • Respiratory tract infection.

Other

  • Pregnant women.
  • New or current smoker.

Who the study is looking for

  • Both sexes would be previously diagnosed as bronchial asthma with a cut-off score FEV1: Between 60% and 80% of predicted value or less than 60% of predicted value and FEV1/FVC ratio: May be significantly reduced from normal value 0.75-0.80.
  • The age of the patients will be ranged between 30 and 40 years old.
  • Asthma Control Test(ACT) will be less than 16 can be successfully used to identify those who will be uncontrolled asthma.
  • All patients will be assessed by Hospital Anxiety and Depression Scale (HADS) ;A cut-off score of 11-15 a moderate depression/anxiety level.
  • Patients who are conscious and cooperative.
  • Patients who are able to understand and follow instruction.

Age in the registry: 30 years to 40 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
October 6 university hospital outpatient chest department
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.